March 1 (Reuters) - Algernon Pharmaceuticals Inc AGN.CD :
* ALGERNON PHARMACEUTICALS TO CONDUCT PHASE 1 DMT STROKE PROGRAM STUDY WITH HAMMERSMITH MEDICINES RESEARCH (UK)
March 1 (Reuters) - Algernon Pharmaceuticals Inc AGN.CD :
* ALGERNON PHARMACEUTICALS TO CONDUCT PHASE 1 DMT STROKE PROGRAM STUDY WITH HAMMERSMITH MEDICINES RESEARCH (UK)